$DHR stock has now risen 2% today, according to our price data from Polygon. There has been approximately $626,890,023 of trading volume.
Here is what we see in our data on $DHR (you can track the company live on Quiver's $DHR stock page):$DHR Insider Trading Activity
$DHR insiders have traded $DHR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- STEVEN M RALES (Chairman) has made 0 purchases and 8 sales selling 1,250,000 shares for an estimated $245,919,390.
- CHRISTOPHER PAUL RILEY (Executive Vice President) has made 0 purchases and 2 sales selling 15,805 shares for an estimated $3,129,424.
- TERI LIST sold 2,778 shares for an estimated $586,319
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DHR Hedge Fund Activity
We have seen 950 institutional investors add shares of $DHR stock to their portfolio, and 1,061 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,976,077 shares (-15.2%) from their portfolio in Q2 2025, for an estimated $587,894,250
- EAGLE CAPITAL MANAGEMENT LLC added 2,859,518 shares (+inf%) to their portfolio in Q2 2025, for an estimated $564,869,185
- MARSHALL WACE, LLP removed 2,761,062 shares (-76.6%) from their portfolio in Q2 2025, for an estimated $545,420,187
- CITADEL ADVISORS LLC removed 2,549,058 shares (-96.7%) from their portfolio in Q2 2025, for an estimated $503,540,917
- PARNASSUS INVESTMENTS, LLC added 2,489,510 shares (+65.0%) to their portfolio in Q2 2025, for an estimated $491,777,805
- VIKING GLOBAL INVESTORS LP added 2,455,994 shares (+543.9%) to their portfolio in Q2 2025, for an estimated $485,157,054
- GENERATION INVESTMENT MANAGEMENT LLP added 1,787,522 shares (+56.2%) to their portfolio in Q2 2025, for an estimated $353,107,095
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DHR Government Contracts
We have seen $110,320,971 of award payments to $DHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $3,970,565
- POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
- AB SCIEX SERVICE & MAINTENANCE AGREEMENT SUPPORT: $3,403,150
- IN-VITRO REAGENTS - VISN 15, ORDERING PERIOD ONE: $2,898,933
- IN-VITRO REAGENTS: $2,304,881
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$DHR Congressional Stock Trading
Members of Congress have traded $DHR stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/03, 06/11 and 0 sales.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 08/28.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/22.
- REPRESENTATIVE PETE SESSIONS sold up to $100,000 on 06/12.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DHR Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- B of A Securities issued a "Buy" rating on 09/22/2025
- UBS issued a "Buy" rating on 07/23/2025
- Baird issued a "Outperform" rating on 07/23/2025
- Guggenheim issued a "Buy" rating on 07/23/2025
- Scotiabank issued a "Sector Outperform" rating on 07/11/2025
- Barclays issued a "Overweight" rating on 06/24/2025
To track analyst ratings and price targets for $DHR, check out Quiver Quantitative's $DHR forecast page.
$DHR Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 13 analysts offer price targets for $DHR in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Ed Ridley-Day from Rothschild & Co set a target price of $220.0 on 10/08/2025
- Vijay Kumar from Evercore ISI Group set a target price of $245.0 on 10/07/2025
- Derik De Bruin from B of A Securities set a target price of $220.0 on 09/22/2025
- Dan Leonard from UBS set a target price of $225.0 on 07/23/2025
- Catherine Schulte from Baird set a target price of $229.0 on 07/23/2025
- Subbu Nambi from Guggenheim set a target price of $250.0 on 07/23/2025
- Brandon Couillard from Wells Fargo set a target price of $205.0 on 07/23/2025
You can track data on $DHR on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
